Loading...
•
Mar 31, 2022
Ultragenyx Q1 2022 Earnings Report
Ultragenyx reported first quarter results with a total revenue of $79.9 million and reaffirmed financial guidance for 2022.
Key Takeaways
Ultragenyx reported a total revenue of $79.9 million for the first quarter of 2022. The company reaffirmed its 2022 revenue guidance for Crysvita and Dojolvi.
Total revenue for the first quarter of 2022 was $79.9 million.
Crysvita revenue in Ultragenyx territories was $54.6 million.
Dojolvi product sales were $12.4 million.
The company reaffirmed 2022 Crysvita revenue guidance of $250 million to $260 million and Dojolvi revenue guidance of $55 million to $65 million.
Revenue by Segment
Revenue by Geographic Location
Forward Guidance
The company continues to expect 2022 revenue for Crysvita in Ultragenyx territories to be between $250 million and $260 million and Dojolvi revenue to be between $55 million and $65 million.
Revenue & Expenses
Visualization of income flow from segment revenue to net income
Historical Earnings Impact
Analyze how earnings announcements historically affect stock price performance
Avg. Return Before/After Earnings
Loading earnings performance data...
Loading earnings reaction data...